Nosium AB (SHI B) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

FMCG

Market cap

SEK Million (Micro Cap)

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.12

Return on Equity

-74.11%

Price to Book

0.00

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Jun 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-28.57%

6 Months

-35.63%

1 Year

-70.83%

2 Years

-86.62%

3 Years

-97.44%

4 Years

-97.46%

5 Years

-97.79%

Nosium AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-11.88%

EBIT Growth (5y)

-224.41%

EBIT to Interest (avg)

-5.04

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.10

Sales to Capital Employed (avg)

0.34

Tax Ratio

0.14%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

-0.63

EV to EBITDA

-0.77

EV to Capital Employed

0.11

EV to Sales

0.56

PEG Ratio

Dividend Yield

ROCE (Latest)

-17.12%

ROE (Latest)

-74.11%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 7.69% vs -7.14% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 9.09% vs 90.52% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.40",
          "val2": "1.30",
          "chgp": "7.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.80",
          "val2": "-0.60",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.00",
          "val2": "-1.10",
          "chgp": "9.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-780.20%",
          "val2": "-643.90%",
          "chgp": "-13.63%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -62.03% vs 20.65% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -39.18% vs -665.63% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.10",
          "val2": "18.70",
          "chgp": "-62.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.00",
          "val2": "-7.00",
          "chgp": "28.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "1.40",
          "chgp": "-21.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-34.10",
          "val2": "-24.50",
          "chgp": "-39.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-951.70%",
          "val2": "-463.50%",
          "chgp": "-48.82%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

1.40

1.30

7.69%

Operating Profit (PBDIT) excl Other Income

-0.80

-0.60

-33.33%

Interest

0.20

Exceptional Items

0.00

Consolidate Net Profit

-1.00

-1.10

9.09%

Operating Profit Margin (Excl OI)

-780.20%

-643.90%

-13.63%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 7.69% vs -7.14% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 9.09% vs 90.52% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

7.10

18.70

-62.03%

Operating Profit (PBDIT) excl Other Income

-5.00

-7.00

28.57%

Interest

1.10

1.40

-21.43%

Exceptional Items

0.00

Consolidate Net Profit

-34.10

-24.50

-39.18%

Operating Profit Margin (Excl OI)

-951.70%

-463.50%

-48.82%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -62.03% vs 20.65% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -39.18% vs -665.63% in Dec 2023

All Annual Results

Company CV

About Nosium AB

Nosium AB

FMCG

Scandinavian Health Innovations AB (publ), formerly Dr Sannas AB (publ), is a Sweden-based holding company engaged in the manufacturing of ecological cosmetics. The Company offers natural skin care and health products, such as Health Soap, body lotion, foot balm, multi cream, hand cream, as well as Sannas Soldryck, which is a dietary supplement with anti-inflammatory seasoning mix. The products do not contain synthetic surfactants, water softeners, preservatives and perfumes. The Company sells products through approximately 80 retailers throughout Sweden, including health clinics, studios and therapists, as well as through the Company’s online store. The Company operates through wholly owned subsidiaries, Dr Sannas Sweden AB and Dr Sannas International AB.

Company Coordinates

Company Details

Artillerigatan 6 , STOCKHOLM None : 114 51

Tel: 46 8 301088

https://scandinavianhealthinnovations.se/

Registrar Details